URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Robert Holloway

Concepts (521)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Stroke
23
2000
134
8.170
Why?
Parkinson Disease
35
1998
404
6.010
Why?
Neurology
14
1996
93
3.820
Why?
Antiparkinson Agents
11
1998
111
2.720
Why?
Decision Making
7
2005
223
2.650
Why?
Cost-Benefit Analysis
22
1996
215
2.480
Why?
Thiazoles
9
1998
90
2.420
Why?
Health Care Costs
10
1996
113
2.230
Why?
Terminal Care
4
2007
70
2.220
Why?
Evidence-Based Medicine
8
1999
202
2.150
Why?
Humans
127
1995
36274
2.140
Why?
Quality-Adjusted Life Years
14
1997
53
2.120
Why?
Withholding Treatment
3
2005
42
2.060
Why?
Palliative Care
7
2007
159
1.950
Why?
Levodopa
9
2000
113
1.900
Why?
Patient Preference
3
2011
9
1.860
Why?
Biomedical Research
7
2003
139
1.730
Why?
Quality of Life
14
2000
502
1.650
Why?
Nervous System Diseases
5
1998
147
1.650
Why?
Research Design
7
2004
336
1.630
Why?
Medical Errors
5
2001
34
1.500
Why?
Cyclohexanecarboxylic Acids
4
2005
48
1.380
Why?
Amines
4
2005
65
1.370
Why?
Treatment Outcome
23
1998
2615
1.340
Why?
gamma-Aminobutyric Acid
4
2005
98
1.340
Why?
Middle Aged
46
1996
9837
1.320
Why?
Brain Ischemia
7
1996
86
1.260
Why?
Analgesics
3
2007
117
1.250
Why?
Hospitals
4
2001
65
1.240
Why?
Antidepressive Agents, Tricyclic
2
2007
31
1.190
Why?
Drug Industry
5
2006
28
1.190
Why?
Academic Medical Centers
4
1996
90
1.180
Why?
Multiple Sclerosis
3
1997
129
1.130
Why?
Aged
36
1996
7269
1.120
Why?
Patient Participation
3
2009
73
1.120
Why?
Clinical Trials as Topic
8
2000
671
1.110
Why?
Epilepsy
4
2005
165
1.070
Why?
United States
22
1998
2688
1.070
Why?
Ischemic Attack, Transient
3
1996
41
1.060
Why?
Referral and Consultation
5
1999
196
1.060
Why?
Interferon-beta
4
2001
63
1.040
Why?
Antibodies, Monoclonal
3
2007
711
1.030
Why?
Radiopharmaceuticals
3
2000
48
1.010
Why?
Female
53
1996
19838
0.980
Why?
Models, Economic
4
2001
28
0.970
Why?
Practice Guidelines as Topic
5
1999
302
0.970
Why?
Delivery of Health Care
3
2008
146
0.950
Why?
Questionnaires
10
2002
1004
0.950
Why?
Membrane Transport Proteins
3
2000
64
0.940
Why?
Randomized Controlled Trials as Topic
8
2001
411
0.930
Why?
Quality Assurance, Health Care
4
1998
123
0.930
Why?
Decision Support Techniques
5
1996
74
0.920
Why?
Aged, 80 and over
18
2001
2529
0.920
Why?
Conflict of Interest
3
2005
37
0.910
Why?
Professional-Family Relations
2
2010
62
0.900
Why?
Male
49
1996
19675
0.890
Why?
Cerebrovascular Disorders
3
1996
115
0.890
Why?
Myositis, Inclusion Body
2
2001
22
0.880
Why?
Parkinsonian Disorders
3
2000
28
0.870
Why?
Health Status Indicators
2
2010
107
0.870
Why?
Cocaine
3
2000
79
0.870
Why?
Life Support Care
2
2011
24
0.860
Why?
Disclosure
2
2008
36
0.830
Why?
Benzothiazoles
11
1998
54
0.820
Why?
Dopamine
3
2000
198
0.820
Why?
Patient Care
1
2012
40
0.810
Why?
Dopamine Agonists
4
2000
29
0.810
Why?
Advance Directives
1
2011
22
0.800
Why?
Corpus Striatum
2
2000
152
0.800
Why?
Membrane Glycoproteins
4
1989
366
0.790
Why?
Dopamine Agents
2
2000
31
0.780
Why?
Medicare
4
2006
129
0.780
Why?
Hospitalization
3
2010
399
0.770
Why?
Magnetic Resonance Angiography
1
2011
37
0.760
Why?
Immunologic Factors
2
2007
66
0.740
Why?
Desipramine
2
2007
36
0.740
Why?
Craniotomy
1
2010
17
0.740
Why?
Infarction, Middle Cerebral Artery
1
2010
16
0.740
Why?
Tracheostomy
1
2010
19
0.730
Why?
Pleurodesis
1
2010
4
0.720
Why?
Talc
1
2010
5
0.720
Why?
Pleural Effusion, Malignant
1
2010
10
0.720
Why?
Diffusion Magnetic Resonance Imaging
2
2007
67
0.710
Why?
Tomography, Emission-Computed, Single-Photon
5
2000
70
0.710
Why?
Carotid Arteries
1
2011
100
0.710
Why?
Dementia
5
1999
102
0.690
Why?
Time Factors
7
2005
3182
0.690
Why?
Drugs, Generic
1
2009
10
0.690
Why?
Drug Costs
1
2009
25
0.690
Why?
Hospital Mortality
4
2007
137
0.690
Why?
Catheters, Indwelling
1
2010
70
0.680
Why?
Placebos
5
2001
178
0.680
Why?
Selegiline
1
2009
69
0.670
Why?
Adult
28
1996
11351
0.650
Why?
Diagnostic Errors
2
2005
90
0.650
Why?
Brain Injuries
1
2010
106
0.640
Why?
Economics, Pharmaceutical
1
2008
6
0.620
Why?
Societies, Medical
2
2008
138
0.620
Why?
Prognosis
6
1995
1083
0.620
Why?
Benchmarking
2
2005
44
0.620
Why?
Endarterectomy, Carotid
3
1998
32
0.610
Why?
Diabetic Neuropathies
1
2008
39
0.600
Why?
Mortality
2
2005
89
0.600
Why?
Central Nervous System
1
2008
113
0.590
Why?
Anticonvulsants
2
2005
122
0.590
Why?
Internet
1
2008
98
0.590
Why?
Health Services Accessibility
1
2009
189
0.590
Why?
Iatrogenic Disease
1
2007
26
0.590
Why?
Central Nervous System Diseases
2
1997
57
0.580
Why?
Neuralgia, Postherpetic
1
2007
26
0.580
Why?
Diagnostic Techniques and Procedures
1
2006
10
0.570
Why?
Choice Behavior
1
2007
46
0.570
Why?
Health Services Research
2
2003
118
0.560
Why?
Nerve Tissue Proteins
3
2000
322
0.550
Why?
Double-Blind Method
10
2000
992
0.550
Why?
Biological Markers
4
2002
560
0.550
Why?
Patient Satisfaction
2
2007
226
0.550
Why?
Health Status
3
2004
283
0.550
Why?
Diagnostic Tests, Routine
1
2006
46
0.550
Why?
Reflex, Babinski
1
2005
1
0.540
Why?
Brain
4
1996
1214
0.540
Why?
Publishing
1
2006
45
0.540
Why?
Length of Stay
5
1998
287
0.530
Why?
Malpractice
2
2001
18
0.530
Why?
Antiemetics
2
2005
56
0.530
Why?
Sleep Apnea, Obstructive
1
2005
14
0.520
Why?
Scopolamine Hydrobromide
1
2005
11
0.510
Why?
Cranial Fossa, Posterior
1
2005
8
0.510
Why?
Quality Indicators, Health Care
2
2001
55
0.500
Why?
Periodicals as Topic
1
2006
79
0.500
Why?
HIV Infections
3
1996
579
0.490
Why?
Substantia Nigra
1
2005
76
0.490
Why?
Outcome Assessment (Health Care)
6
2001
301
0.490
Why?
Antipsychotic Agents
1
2006
114
0.480
Why?
Severity of Illness Index
7
2001
922
0.480
Why?
Vomiting
1
2005
115
0.480
Why?
Acquired Immunodeficiency Syndrome
2
1995
193
0.470
Why?
Hospital Departments
1
2003
16
0.460
Why?
New York
8
1999
1305
0.460
Why?
Research
2
1998
178
0.460
Why?
Risk Management
1
2003
18
0.460
Why?
Neurosurgical Procedures
4
2005
43
0.450
Why?
HIV-1
3
1995
536
0.450
Why?
Education, Medical, Undergraduate
1
2004
93
0.440
Why?
Physician's Practice Patterns
3
1999
243
0.440
Why?
Patient Selection
2
2003
212
0.430
Why?
Mass Screening
1
2005
247
0.420
Why?
Antidepressive Agents
1
2003
93
0.420
Why?
Carrier Proteins
2
2000
426
0.420
Why?
Research Subjects
3
2008
17
0.420
Why?
Outcome and Process Assessment (Health Care)
2
2001
85
0.410
Why?
Proportional Hazards Models
5
2000
450
0.410
Why?
Anticoagulants
2
2000
135
0.400
Why?
Disability Evaluation
5
2007
124
0.400
Why?
Magnetic Resonance Imaging
5
1996
991
0.400
Why?
Electric Stimulation Therapy
1
2001
29
0.390
Why?
Health Care Rationing
1
2000
6
0.380
Why?
Adjuvants, Immunologic
1
2001
117
0.380
Why?
Critical Pathways
1
2000
11
0.370
Why?
Reproducibility of Results
8
2003
877
0.370
Why?
Communication
3
2005
273
0.360
Why?
Decision Trees
4
1996
29
0.360
Why?
G(M1) Ganglioside
1
1999
7
0.360
Why?
Quality of Health Care
3
2007
209
0.360
Why?
Autoimmune Diseases of the Nervous System
1
1999
6
0.360
Why?
Motor Neuron Disease
1
1999
7
0.360
Why?
Risk Assessment
7
2005
884
0.350
Why?
Depressive Disorder
1
2003
318
0.350
Why?
Education, Medical, Continuing
2
1999
64
0.350
Why?
Fibrinolytic Agents
3
2001
61
0.350
Why?
Research Support as Topic
3
2006
53
0.350
Why?
Aorta, Thoracic
1
2000
72
0.350
Why?
Multiple Sclerosis, Relapsing-Remitting
2
2007
22
0.340
Why?
Sensitivity and Specificity
8
1996
905
0.340
Why?
Autoantibodies
1
1999
98
0.340
Why?
Antibodies, Monoclonal, Humanized
3
2007
87
0.340
Why?
Markov Chains
4
1999
40
0.340
Why?
Physicians
1
2001
157
0.340
Why?
Safety Management
3
2004
30
0.330
Why?
Medication Errors
3
2003
18
0.330
Why?
Brachial Plexus
1
1998
3
0.330
Why?
Hypertension, Pulmonary
1
1999
29
0.330
Why?
Clavicle
1
1998
19
0.330
Why?
Young Adult
4
2009
1059
0.320
Why?
Iodine Radioisotopes
3
2000
100
0.320
Why?
Retrospective Studies
8
1998
2267
0.320
Why?
Gene Transfer Techniques
3
2006
147
0.320
Why?
Enzyme-Linked Immunosorbent Assay
1
1999
462
0.310
Why?
Inpatients
2
1996
72
0.310
Why?
Migraine Disorders
2
2006
18
0.310
Why?
Fractures, Bone
1
1998
95
0.310
Why?
Thrombosis
1
2000
200
0.300
Why?
Anti-HIV Agents
1
1999
172
0.300
Why?
Data Collection
4
1999
215
0.300
Why?
Clinical Protocols
1
1998
106
0.300
Why?
Carotid Stenosis
2
2005
51
0.300
Why?
Attitude of Health Personnel
1
2000
289
0.300
Why?
Attitude to Health
3
2003
208
0.290
Why?
Biopsy
2
1996
362
0.290
Why?
Pilot Projects
5
2001
442
0.290
Why?
Comorbidity
3
1998
380
0.290
Why?
Great Britain
3
2002
97
0.290
Why?
Cross-Sectional Studies
3
2003
654
0.280
Why?
Cost of Illness
3
2004
79
0.280
Why?
Toxoplasmosis, Cerebral
1
1996
5
0.280
Why?
Costs and Cost Analysis
1
1996
90
0.270
Why?
Ethics Committees, Research
2
2003
17
0.270
Why?
Cerebral Hemorrhage
2
1996
61
0.270
Why?
Observer Variation
3
2000
144
0.260
Why?
Cohort Studies
5
2007
969
0.260
Why?
Headache
1
1995
50
0.260
Why?
Forecasting
2
2005
177
0.260
Why?
Disease Progression
3
2002
521
0.250
Why?
International Classification of Diseases
2
2007
15
0.250
Why?
Guideline Adherence
2
1999
83
0.250
Why?
Tomography, X-Ray Computed
4
1997
759
0.250
Why?
Adolescent
5
1996
4766
0.250
Why?
Dopamine Plasma Membrane Transport Proteins
3
2000
33
0.250
Why?
Cause of Death
2
2011
162
0.240
Why?
Sickness Impact Profile
2
2002
41
0.240
Why?
Thrombolytic Therapy
2
2009
65
0.230
Why?
Predictive Value of Tests
5
1999
606
0.220
Why?
Life Support Systems
1
2012
3
0.220
Why?
Advance Directive Adherence
1
2012
3
0.220
Why?
Age Factors
2
1996
1128
0.220
Why?
Cardiopulmonary Resuscitation
1
2012
25
0.210
Why?
Accidental Falls
2
2007
50
0.210
Why?
Financing, Government
2
2009
28
0.210
Why?
Endometrial Neoplasms
1
2012
37
0.210
Why?
Intensive Care Units
2
1998
111
0.210
Why?
Diagnostic Imaging
3
1999
87
0.210
Why?
Tissue Plasminogen Activator
1
2012
52
0.210
Why?
Government Agencies
2
2008
13
0.210
Why?
American Heart Association
2
2008
24
0.210
Why?
Patient Care Team
2
2000
192
0.210
Why?
Drug Approval
2
2006
20
0.210
Why?
Neurosurgery
1
2012
9
0.210
Why?
Risk Factors
5
2000
2345
0.200
Why?
Odds Ratio
2
2010
315
0.200
Why?
National Institutes of Health (U.S.)
2
2006
63
0.200
Why?
Plasma Exchange
1
2011
18
0.200
Why?
Enteral Nutrition
1
2011
34
0.200
Why?
Genital Neoplasms, Female
1
2011
33
0.200
Why?
Albuterol
1
2001
21
0.200
Why?
Narration
1
2011
23
0.200
Why?
Endpoint Determination
1
2011
31
0.200
Why?
Gynecologic Surgical Procedures
1
2011
13
0.200
Why?
Immunoglobulins, Intravenous
1
2011
36
0.200
Why?
Recurrence
3
2007
691
0.200
Why?
Truth Disclosure
1
2011
23
0.200
Why?
Muscular Dystrophy, Facioscapulohumeral
1
2001
21
0.200
Why?
Adrenergic beta-Agonists
1
2001
51
0.200
Why?
Leukoencephalopathy, Progressive Multifocal
2
2007
16
0.200
Why?
Hospital Costs
1
2011
35
0.200
Why?
Patient Protection and Affordable Care Act
1
2011
5
0.200
Why?
Time
2
2007
46
0.200
Why?
Drug Therapy, Combination
2
1999
382
0.200
Why?
Myasthenia Gravis
1
2011
63
0.200
Why?
Hospitals, Special
1
2011
7
0.190
Why?
Family
1
2012
201
0.190
Why?
Celiac Disease
1
2010
21
0.190
Why?
Robotics
1
2011
76
0.190
Why?
Endoscopy, Gastrointestinal
1
2010
26
0.190
Why?
Angioplasty
1
2010
31
0.180
Why?
Reimbursement, Incentive
1
2010
11
0.180
Why?
Patient Acceptance of Health Care
2
2008
110
0.180
Why?
Physician's Role
1
2011
129
0.180
Why?
Health Facilities
1
2009
5
0.180
Why?
Health Services Needs and Demand
1
2011
103
0.180
Why?
Therapeutic Misconception
1
2009
3
0.180
Why?
Curriculum
2
1999
236
0.180
Why?
Hospitals, Veterans
1
2009
17
0.180
Why?
Immunosuppressive Agents
1
2011
200
0.180
Why?
Prescriptions
1
2009
6
0.170
Why?
Geriatric Assessment
1
2011
158
0.170
Why?
United States Department of Veterans Affairs
1
2009
30
0.170
Why?
Ethics, Research
2
2005
16
0.170
Why?
Drug and Narcotic Control
1
2009
10
0.170
Why?
Acute Disease
3
2001
586
0.170
Why?
Disease
1
2009
36
0.170
Why?
Hot Flashes
1
2009
28
0.170
Why?
Neurologic Examination
2
2005
146
0.170
Why?
Postoperative Complications
3
1998
733
0.170
Why?
Sleep
1
2009
59
0.170
Why?
Medicaid
2
2006
93
0.170
Why?
European Continental Ancestry Group
1
2011
234
0.170
Why?
United States Dept. of Health and Human Services
1
2008
4
0.170
Why?
Managed Care Programs
2
1999
80
0.160
Why?
Women's Health
1
2009
60
0.160
Why?
Coronary Artery Disease
1
2010
96
0.160
Why?
Health Services
2
2006
66
0.160
Why?
Consent Forms
1
2008
4
0.160
Why?
Clinical Trials, Phase I as Topic
1
2008
10
0.160
Why?
Health Expenditures
2
2005
43
0.160
Why?
Fees and Charges
1
2008
13
0.160
Why?
Financial Support
1
2008
5
0.160
Why?
Public Opinion
1
2008
17
0.160
Why?
African Americans
1
2011
219
0.160
Why?
Trust
1
2008
30
0.160
Why?
Telemedicine
1
2009
43
0.160
Why?
Risk Reduction Behavior
1
2008
39
0.160
Why?
Psychometrics
2
2003
223
0.160
Why?
Guidelines as Topic
1
2008
89
0.160
Why?
Perception
1
2008
65
0.160
Why?
Diagnosis, Differential
2
1995
874
0.160
Why?
Income
1
2008
74
0.160
Why?
Ethics, Clinical
1
2008
13
0.160
Why?
Thiophenes
1
2008
17
0.160
Why?
Patient Education as Topic
1
2009
214
0.150
Why?
Medical Records
2
2003
124
0.150
Why?
Emergency Medical Services
1
2009
134
0.150
Why?
Disorders of Excessive Somnolence
1
2007
8
0.150
Why?
Hallucinations
1
2007
14
0.150
Why?
Survival Rate
1
2010
618
0.150
Why?
Demography
3
1998
101
0.150
Why?
Insurance Claim Reporting
1
2007
7
0.150
Why?
Neurosciences
1
2006
7
0.140
Why?
Population Growth
1
2006
7
0.140
Why?
Epilepsy, Temporal Lobe
1
2007
47
0.140
Why?
Population Density
1
2006
15
0.140
Why?
Self Disclosure
1
2007
38
0.140
Why?
Internationality
1
2006
26
0.140
Why?
Edema
1
2007
109
0.140
Why?
Nerve Fibers, Myelinated
1
2007
38
0.140
Why?
Cognition Disorders
2
2007
286
0.140
Why?
Peer Review, Research
1
2006
24
0.140
Why?
Dizziness
1
2006
13
0.140
Why?
Human Experimentation
1
2006
16
0.140
Why?
Education, Medical, Graduate
2
2000
109
0.140
Why?
Databases, Factual
1
2007
156
0.140
Why?
Physician-Patient Relations
1
2010
359
0.140
Why?
Toes
1
2005
13
0.130
Why?
Therapeutic Human Experimentation
1
2005
4
0.130
Why?
Health Services Misuse
1
2005
11
0.130
Why?
Polysomnography
1
2005
23
0.130
Why?
Positive-Pressure Respiration
1
2005
26
0.130
Why?
Cholesteatoma
1
2005
2
0.130
Why?
Tetrabenazine
1
2005
5
0.130
Why?
Fluorine Radioisotopes
1
2005
8
0.130
Why?
Dihydroxyphenylalanine
1
2005
22
0.130
Why?
Carbon Radioisotopes
1
2005
77
0.130
Why?
Receptors, Dopamine
1
2005
24
0.130
Why?
Fluorodeoxyglucose F18
1
2005
17
0.130
Why?
Biotransformation
1
2005
113
0.130
Why?
Computer User Training
1
2004
1
0.120
Why?
Positron-Emission Tomography
1
2005
39
0.120
Why?
Hospital Information Systems
1
2004
8
0.120
Why?
Neuropsychological Tests
3
1996
386
0.120
Why?
Hospitals, University
1
2004
76
0.120
Why?
Respiration, Artificial
1
2005
174
0.120
Why?
Medical Records Systems, Computerized
1
2004
34
0.120
Why?
Blood-Brain Barrier
1
2005
108
0.120
Why?
Follow-Up Studies
3
1998
1855
0.120
Why?
Informed Consent
3
2006
84
0.110
Why?
Animals
4
2002
16093
0.110
Why?
Logistic Models
1
2006
611
0.110
Why?
Median Neuropathy
1
2003
3
0.110
Why?
Teaching
1
2004
118
0.110
Why?
Educational Measurement
1
2004
122
0.110
Why?
Survival Analysis
1
2005
606
0.110
Why?
Neoplasms
1
2010
739
0.110
Why?
Electrodiagnosis
1
2003
49
0.110
Why?
Program Evaluation
2
1999
206
0.110
Why?
Urinary Calculi
1
2002
32
0.110
Why?
Breast Diseases
1
2002
27
0.100
Why?
Hypotension, Orthostatic
1
2002
11
0.100
Why?
Movement Disorders
3
2004
52
0.100
Why?
Neopterin
1
2001
5
0.100
Why?
Nerve Degeneration
1
2002
67
0.100
Why?
Expert Testimony
1
2001
14
0.100
Why?
Jurisprudence
1
2001
11
0.100
Why?
Clinical Competence
1
2004
261
0.100
Why?
Cerebral Angiography
2
1998
57
0.100
Why?
Sleep Disorders
1
2002
69
0.100
Why?
Safety
1
2001
101
0.090
Why?
Dyskinesias
1
2000
9
0.090
Why?
Regression Analysis
1
2002
527
0.090
Why?
Job Application
1
2000
4
0.090
Why?
Echocardiography, Transesophageal
1
2000
52
0.090
Why?
Educational Technology
1
1999
4
0.090
Why?
Warfarin
1
2000
48
0.090
Why?
Endarterectomy
1
1999
13
0.090
Why?
CD4 Lymphocyte Count
1
1999
148
0.080
Why?
Enbucrilate
1
1998
3
0.080
Why?
Cerebral Veins
1
1998
11
0.080
Why?
Dura Mater
1
1998
12
0.080
Why?
Tissue Adhesives
1
1998
12
0.080
Why?
Heparin
1
2000
122
0.080
Why?
Bone Cements
1
1998
15
0.080
Why?
Arteriovenous Fistula
1
1998
21
0.080
Why?
Brain Edema
1
1998
45
0.080
Why?
Embolization, Therapeutic
1
1998
39
0.080
Why?
Image Enhancement
1
2000
145
0.080
Why?
AIDS Dementia Complex
1
1999
141
0.080
Why?
Prospective Studies
3
2005
1689
0.070
Why?
Feasibility Studies
2
2004
202
0.070
Why?
Models, Statistical
1
1999
226
0.070
Why?
Motivation
2
2008
156
0.070
Why?
Neurons
1
2005
1083
0.070
Why?
Medical Laboratory Science
1
1996
6
0.070
Why?
Models, Theoretical
1
1998
192
0.070
Why?
Factor Analysis, Statistical
2
2003
57
0.070
Why?
Stereotaxic Techniques
1
1996
33
0.070
Why?
Subarachnoid Hemorrhage
1
1996
28
0.070
Why?
Cerebral Infarction
1
1996
49
0.070
Why?
Evaluation Studies as Topic
1
1996
245
0.070
Why?
Treatment Failure
1
1996
128
0.070
Why?
Internship and Residency
1
2000
333
0.070
Why?
Placebo Effect
2
2005
35
0.070
Why?
Alzheimer Disease
1
1999
294
0.070
Why?
Drug Interactions
1
1995
183
0.060
Why?
Prevalence
2
2006
562
0.060
Why?
Cognition
1
1996
227
0.060
Why?
Spirituality
1
2012
10
0.050
Why?
Chronic Pain
1
2012
9
0.050
Why?
Surgical Procedures, Minimally Invasive
1
2011
30
0.050
Why?
Hand Strength
1
2001
26
0.050
Why?
Propensity Score
1
2011
6
0.050
Why?
Monte Carlo Method
1
2011
58
0.050
Why?
Observation
1
2011
13
0.050
Why?
Neoplasm Staging
1
2012
338
0.050
Why?
Combined Modality Therapy
1
2012
486
0.050
Why?
Caregivers
1
2012
76
0.050
Why?
Microvilli
1
2010
37
0.050
Why?
Video Recording
1
2010
54
0.050
Why?
Body Mass Index
1
2001
218
0.050
Why?
Gastrointestinal Hemorrhage
1
2011
84
0.050
Why?
Survivors
1
2012
118
0.050
Why?
Multicenter Studies as Topic
1
2000
129
0.050
Why?
Health Facility Administration
1
2009
3
0.040
Why?
Ergotamines
1
2009
2
0.040
Why?
Tryptamines
1
2009
2
0.040
Why?
Ketorolac
1
2009
4
0.040
Why?
Federal Government
1
2009
7
0.040
Why?
Forms and Records Control
1
2009
17
0.040
Why?
United States Food and Drug Administration
1
2009
45
0.040
Why?
Clinical Laboratory Techniques
1
2009
38
0.040
Why?
Menopause
1
2009
43
0.040
Why?
Stents
1
2010
129
0.040
Why?
Narcotics
1
2009
44
0.040
Why?
Drug Discovery
1
2009
10
0.040
Why?
Extracellular Matrix Proteins
1
1989
74
0.040
Why?
Exons
1
1989
168
0.040
Why?
Introns
1
1989
111
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2009
92
0.040
Why?
Joint Commission on Accreditation of Healthcare Organizations
1
2008
6
0.040
Why?
Veterans
1
2009
50
0.040
Why?
Chi-Square Distribution
1
2009
344
0.040
Why?
Longitudinal Studies
1
2010
395
0.040
Why?
Mental Disorders
1
2012
347
0.040
Why?
Single-Blind Method
1
2008
116
0.040
Why?
Glycoproteins
1
1989
201
0.040
Why?
Extracellular Matrix
1
1989
162
0.040
Why?
Biotechnology
1
2006
18
0.040
Why?
Patient Care Planning
1
2007
71
0.040
Why?
Sex Distribution
1
2007
160
0.040
Why?
Efficiency, Organizational
1
2006
34
0.040
Why?
Age Distribution
1
2007
221
0.040
Why?
Health Knowledge, Attitudes, Practice
1
2009
267
0.030
Why?
Heart Diseases
1
2007
142
0.030
Why?
Health Care Surveys
1
2007
161
0.030
Why?
Myocardial Infarction
1
2011
660
0.030
Why?
Causality
1
2005
45
0.030
Why?
Temporal Lobe
1
2007
127
0.030
Why?
Brain Tissue Transplantation
1
2005
23
0.030
Why?
Aspirin
1
2005
59
0.030
Why?
Platelet Aggregation Inhibitors
1
2005
61
0.030
Why?
Canada
1
2005
75
0.030
Why?
Voluntary Programs
1
2004
2
0.030
Why?
Sentinel Surveillance
1
2004
2
0.030
Why?
Computer Literacy
1
2004
3
0.030
Why?
Systems Analysis
1
2004
7
0.030
Why?
Drug Tolerance
1
2004
35
0.030
Why?
Staff Development
1
2004
26
0.030
Why?
Feedback
1
2004
76
0.030
Why?
Socioeconomic Factors
1
2006
404
0.030
Why?
Administration, Oral
1
2005
308
0.030
Why?
Activities of Daily Living
1
2006
261
0.030
Why?
Incidence
1
2006
685
0.030
Why?
Stem Cell Transplantation
1
2005
110
0.030
Why?
Statistical Distributions
1
2003
8
0.030
Why?
History, 20th Century
1
2004
244
0.030
Why?
Likelihood Functions
1
2003
52
0.030
Why?
Wrist
1
2003
50
0.030
Why?
Bayes Theorem
1
2003
39
0.030
Why?
ROC Curve
1
2003
126
0.030
Why?
Hospitals, Teaching
1
2002
81
0.030
Why?
Sex Factors
1
2005
597
0.030
Why?
Electromyography
1
2003
172
0.030
Why?
Neural Conduction
1
2003
139
0.030
Why?
Dose-Response Relationship, Drug
1
2005
1117
0.030
Why?
Patient Admission
1
2002
85
0.030
Why?
Reference Values
1
2003
439
0.020
Why?
Family Practice
1
2002
181
0.020
Why?
Technology Assessment, Biomedical
1
2000
21
0.020
Why?
American Medical Association
1
2000
4
0.020
Why?
Emergency Service, Hospital
1
2002
213
0.020
Why?
Education
1
1999
40
0.020
Why?
Health Policy
1
2000
78
0.020
Why?
Cerebral Arteries
1
1998
39
0.020
Why?
Caudate Nucleus
1
1996
22
0.020
Why?
Atrophy
1
1996
66
0.020
Why?
Hippocampus
1
1996
211
0.020
Why?
Child
1
2002
4155
0.010
Why?
Complement Factor B
1
1989
5
0.010
Why?
Single-Strand Specific DNA and RNA Endonucleases
1
1989
4
0.010
Why?
Complement C2
1
1989
8
0.010
Why?
Endonucleases
1
1989
17
0.010
Why?
DNA Restriction Enzymes
1
1989
86
0.010
Why?
von Willebrand Factor
1
1989
59
0.010
Why?
Integrins
1
1989
48
0.010
Why?
Sequence Homology, Nucleic Acid
1
1989
141
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
1989
79
0.010
Why?
Microscopy, Electron
1
1989
377
0.010
Why?
Epidermal Growth Factor
1
1989
112
0.010
Why?
RNA Splicing
1
1989
142
0.010
Why?
Promoter Regions, Genetic
1
1989
553
0.010
Why?
Amino Acid Sequence
1
1989
1195
0.010
Why?
Transcription, Genetic
1
1989
812
0.010
Why?
Base Sequence
1
1989
1683
0.010
Why?
Molecular Sequence Data
1
1989
1988
0.010
Why?

Visualizations


Holloway's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department